Halozyme Therapeutics Inc banner

Dividends

Halozyme Therapeutics Inc
does not pay dividends

Shareholder Yield

Current shareholder yield for RV7 is .

Shareholder Yield

Dividends, buybacks and debt paydown, as one yield.

Create a free account · No card needed

Dividend Yield
No dividends
Buyback Yield

Create a free account · No card needed

Debt Paydown Yield

Create a free account · No card needed

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Price Appreciation

RV7 Price
Halozyme Therapeutics Inc

Annual Price Range
91.64
52w Low
52.5
52w High
118
Price Metrics
Average Annual Return 26.67%
Standard Deviation of Annual Returns 37.49%
Max Drawdown -51%
Shares Statistics
Market Capitalization 11.5B EUR
Shares Outstanding 127 186 000
Percentage of Shares Shorted
N/A

RV7 Return Decomposition
Main factors of price return

Stock Splits

No Stock Splits Found

We don't have any information about RV7's stock splits.